Characterisation of β-globin gene mutations in Malaysian children: A strategy for the control of β-thalassaemia in a developing country

Journal of Tropical Pediatrics

Volumn 51, Issue 6, 2005, Pages 328-333

  Thong, Meow Keong ^a   Tan, J A M A ^a   Tan, K L ^a   Yap, S F ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN;

ALLELE; ARTICLE; BETA THALASSEMIA; CHILD; CHILD CARE; CONTROLLED STUDY; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; DNA DETERMINATION; ETHNIC DIFFERENCE; ETHNOLOGY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MASS SCREENING; OUTCOMES RESEARCH; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PROTEIN ANALYSIS; THALASSEMIA MAJOR;

BETA-THALASSEMIA; CHILD; DEVELOPING COUNTRIES; DNA; GENE FREQUENCY; GENOTYPE; GLOBINS; HUMANS; MALAYSIA; MUTATION; POLYMERASE CHAIN REACTION;

EID: 31044450333     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmi052     Document Type: Article

References (29)

1. Weatherall DJ, Clegg JB. Thalassaemia - a global public health problem. Nature Med 1996; 3: 47-9.
2. Caro JJ, Ward A, Green TC, et al. Impact of thalassemia major on patients and their families. Acta Haematol 2002; 107: 150-57.
3. Angastiniotis M. Modell B. Global epidemiology of haemoglobin disorders. Ann NY Acad Sci 1998; 850: 251-69.
4. Angastinoitis MA. Prevention of thalassaemia in Cyprus. Lancet 1981; 369-70.
5. Angastinoitis M, Modell B, Englezos P, et al. Prevention and control of haemoglobinopathies. Bulletin of the WHO 1995; 73(3): 375-86.
6. Karnon J, Zeuner D, Brown J, et al. Lifetime treatment costs of beta-thalassemia major. Clin Lab Haematol 1999; 21: 377-85.
7. Ostrowsky J, Lippman A, Scriver C. Cost-benefit analysis of a thalassemia disease prevention program. Am J Public Health 1985; 75: 732-36.
8. Baysal E, Carver MFH. The β and δ thalassaemia repository. Hemoglobin 1995; 19: 213.
9. Huisman THJ, Carver MFH, Baysal E. A syllabus of thalassaemia mutations 1997. http://globin.cse.psu.edu.
10. Kazazian H, Boehm CD. Molecular basis and prenatal diagnosis of β-thalassaemia. Blood 1988; 72: 1107-116.
11. George E, Li HJ, Fei YJ, et al. Types of thalassaaemia among patients attending a large university clinic in Kuala Lumpur, Malaysia. Hemoglobin 1992; 16: 51-66.
12. George E, Khuzaiah R. Malays with thalassaemias in West Malaysia. J Trop Geog Med 1984; 36: 123-25.
13. George-Kodiseri E, Yang KG, Kutlar F, et al. Chinese in West Malaysia: The geography of β-thalassaemia mutations. Singapore Med J 1990; 31: 374-77.
14. George E, George R, Ariffin WA, et al. Spectrum of β-thalassaemia mutations in transfusion dependent thalassaemia patients: Practical implications in prenatal diagnosis. Med J Malaysia 1993; 48: 325-29.
15. Ariffin WA, Normah J, Kham SKY, Tan JAMA. The spectrum of β-thalassaemia mutations in Malays in Singapore and Kelantan. Southeast Asian J Trop Med Public Health 1996; 27: 164-68.
16. Thong MK, Law HY, Ng ISL. Molecular heterogeneity of β-thalassaemia in Malaysia: A practical approach to diagnosis. Ann Acad Med Singapore 1996; 25: 79-83.
17. Thong MK, Rudzki Z, Hall J, Tan JAMA, Chan LL, Yap SF. A single large deletion accounts for all β-globin gene mutations in twenty families in Sabah (north Borneo), Malaysia. Human Mutation 1999; 13: 413.
18. Old JM, Higgs DR. Gene analysis. In: The Thalassaemias. Methods in haematology. Weatherall DJ (ed.), Churchill Livingstone, Edinburgh 1983; pp. 74-82.
19. Tan JAMA, Yap SF, Tan KL, Thong MK. The use of the Amplification Refractory Mutation System (ARMS) as an effective and economical tool for prenatal diagnosis of β-thalassaemia in Malaysian subjects. Int Med Res J 1999; 2: 65-68.
20. Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of β-thalassaemia: Studies in Indian and Cypriot populations in the UK. The Lancet 1990; 336: 834-37.
21. Suhaib Ahmed, Mohammad Saleem, Nadra Sultana et al. Prenatal diagnosis of β-thalassaemia in Pakistan: Experience in a Muslim country. Prenatal Diagnosis 2000; 20: 378-83.
22. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
23. Waye JS, Eng B, Hunt JA, Chui DHK. Filipino β-thalassaemia due to a large deletion: Identification of the deletion endpoints and PCR-based diagnosis. Human Genet 1994; 94: 530-32.
24. Shpilberg O, Dorman J, Ferrell R, et al. The next stage: Molecular epidemiology. J Clin Epidemiol 1997; 50: 633-38.
25. Khoury M, Yang Q. The future of generic studies of complex human diseases: An epidemiologic perspective. Epidemiology 1998; 9: 350-54.
26. Saxena R, Jain P, Thomas E, et al. Prenatal diagnosis of β-thalassaemia: Experience in a developing country. Prenatal Diagnosis 1998; 18: 1-7.
27. Ahmed S, Saleem M, Sultana N, et al. Prenatal diagnosis of β-thalassaemia in Pakistan: Experience in a Muslim country. Prenatal Diagnosis 2000; 20: 378-83.
28. El-Harith, Kuhnau W, Schmidtke J, et al. Identification and clinical presentation of β-thalassaemia mutations in the eastern region of Saudi Arabia. J Med Genet 1999; 36: 935-37.
29. Tan KL, Tan JAMA, Wong YC, Wee YC, Thong MK, Yap SF. Combine-ARMS: A rapid and cost-effective protocol for molecular characterization of β-thalassaemia in Malaysia. Genet Test 2001; 5: 17-22.